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Abstract: Placebo effects are documented in a number of clinical and experimental studies. It 
is possible to benefit from placebo effects in clinical practice by using them as effects additive 
to those of documented and effective treatments. The purpose of this paper is to discuss how 
doctors and other health workers may benefit from placebo effects within an ethical framework. 
A narrative review of the literature relating to placebo effects in clinical practice was performed. 
We searched PubMed and selected textbooks on placebo effects for articles and book chapters 
relating to placebo effects in clinical practice. By drawing on placebo effects, doctors may access 
patients’ self-healing potentials. In practice, doctors may best benefit from placebo effects by 
influencing the patient’s expectations through communication. An important principle is to give 
the patient information stating that a particular treatment is effective, as long as this is based 
on realistic optimism. A patient-centered style involving elements such as developing trust and 
respect, exploring the patient’s values, speaking positively about treatments, and providing 
reassurance and encouragement might aid in activating placebo effects. The total effect of a 
documented treatment will partly depend on how well the placebo effects have been activated. 
Thus, placebo effects can be understood as a form of supplemental treatment.
Keywords: placebo effects, doctor-patient communication, expectations, biopsychosocial 
model
Introduction
The term “placebo” is often used about non-effective medicines that are typically 
referred to as “sugar pills” in colloquial English. However, a number of studies have 
shown that inactive medications have effects if accompanied by positive information 
about the treatment. Placebo effects may thus be defined as psychological and/or physi-
ological responses that follow the administration of active and non-active substances 
when coupled with affirmation of the treatment effects. Placebo effects can even be 
obtained when placebo effects are honestly and clearly described to the patient.1,2
Placebo effects have been studied and observed in relation to a number of condi-
tions, such as pain,3 sleep disorders,4 depression,5 and Parkinson’s disease.6 In addi-
tion, placebo effects may influence the immune system and the endocrine system.7 
In a psychotherapeutic setting, placebo effects may also contribute to some of the 
therapeutic effect.8
Placebo effects have been studied thoroughly for several decades, but the phenom-
enon has been known for hundreds of years. The first placebo-controlled study can be 
traced back to 1799.7 Placebo effects are probaby as ancient as our civilization. It may 
be reasonable to assume that benefits from ancient remedies and herbs in part could 





be related to placebo effects. Beecher was one of the very 
first doctors to illuminate the phenomen of placebo when 
he gave wounded soldiers inert saline injections during the 
Second World War.7 During recent decades, research interest 
in placebo effects has gained ground due to more advanced 
research methods, including the controlling of placebo effects 
in clinical trials.7
Despite the fact that placebo effects are well-documented, 
individual differences can influence placebo effects. Some 
people respond more strongly than others,9 and individual 
differences should be taken into account. Placebo effects may 
be most effective in conditions like pain, depression, and 
motor diseases.7,9 As previously mentioned, placebo effects 
are seen in both experimental and clinical settings. However, 
controlled studies investigating how placebo effects can be 
used as additive effects in clinical practice are still scarce.
Placebo effects can be related to biological, psycho-
logical, and social factors9 and can be understood from a 
biopsychosocial perspective.10 While the biomedical model 
rests mainly on treatment within a physiological and bio-
logical framework, the biopsychosocial model incorporates 
biological, psychological, and social factors.11 An important 
aspect of the biopsychosocial model is the patient-provider 
interaction.12–14
In a treatment setting it is unethical to deliberately 
misinform the patient. However, placebo effects can be an 
important factor in a biopsychosocial context. This paper 
discusses how to take advantage of placebo effects as addi-
tional effects in a clinical setting. We do not focus on placebo 
effects in clinical trials or “pure” placebo treatment (ie, with 
pharmacologically inactive substances). Placebo effects may 
be present even when no medication is prescribed. However, 
we will concentrate on how to utilize placebo effects as 
additive effects, ie, when prescribing substances that are 
pharmacologically active, but where the placebo effects 
might enhance the effectiveness of the medication.
Methods
A narrative review of the literature relating to the placebo 
effect in clinical practice was performed. We used the 
PubMed database and searched for articles in the field of 
placebo and clinical practice. The following search combina-
tions were used: “placebo effect” and “clinical implications” 
(generated 15 hits) and “placebo effect” and “clinical 
practice” (generated 166 hits). We also searched selected 
textbooks on the placebo effect for book chapters relating 
to the placebo effect in clinical practice. In addition, we 
reviewed the reference lists of the included articles to find 
relevant articles missed in the database search. The search 
resulted in more than 180 relevant articles and book chapters, 
from which we selected the papers discussed below. As this 
was a narrative review, we were unable to include and discuss 
all the relevant literature, and have had to select the literature 
that we deemed most relevant to our focus.
Discussion
expectations
An expectation is an imagination of a specific outcome and is 
a central mechanism by which placebo effects may occur.9,15,16 
There is a connection between the degree of expectations and 
the strength of the placebo effects.15,17 Expectations may be 
influenced by verbal information, the appearance of a medi-
cation, previous experiences, and interaction between the 
patient and doctor.9 The strength of placebo effects depends 
on whether the treatment information is positive, negative, 
or neutral. The total effect of a pharmacological treatment 
is thus composed of biologically active ingredients and 
biopsychosocial contextual factors (eg, placebo effects). For 
example, Krell et al found that the effect of one antidepres-
sant was strengthened if the patient had positive expectations 
of the drug.18 Up to 90% of their patients with an expecta-
tion of improvement experienced relief of their depressive 
symptoms when they thought that the medication would be 
“very effective”. By comparison, only 33% experienced 
improvement if they thought the medication was “somewhat 
effective”. A later study found comparable effects.19
Further, Benedetti et al demonstrated the significance of 
expectations in pain relief.20 Patients with postoperative pain 
were administered an intravenous painkiller. Patients who 
were informed that they had received a painkiller experienced 
greater relief than those who lacked this knowledge. 
If a treatment is accompanied by information stating that 
it is in all probability effective, this will positively influence 
the outcome of treatment.21 Enthusiastic information provides 
more pain relief than more neutral information, even if the 
actual treatment remains the same.22,23 Information about a 
biologically active medication may reverse or neutralize the 
pharmacological effect. The patient’s expectations can in some 
cases be of greater significance with regard to the outcome 
than the administered pharmacological substances.24,25
Placebo effects as  
psychophysiological responses
Placebo effects may be considered to be physiological effects 
and not only as results of a social desirability bias.26 This is 
documented in a large number of studies drawing on methods 
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of investigation such as electroencephalography, heart rate 
variability, or functional magnetic resonance imaging.9 For 
instance, Wager et al3 used functional magnetic resonance 
imaging to show that activity in the pain-sensitive areas of 
the brain was reduced after administration of placebos.
Further, it has been assumed that placebo effects are either 
caused or strengthened by a reduction in levels of fear and 
anxiety.27–29 It has been noted that an antidepressant prescribed 
for depression causes a similar activation pattern in the brain 
as treatments with placebo.30 Depressive patients who fail to 
respond to placebo treatments or antidepressants show no 
change in their brain activation pattern.31 These findings indicate 
that emotional factors can be related to placebo effects.27
Clinical implications of placebo effects
Placebo effects may work to strengthen the effect of a particular 
therapy regardless of how well documented the therapy is,21,32,33 
and several studies have shown that many clinicians draw on 
placebo effects in clinical practice.34–36 Two studies, from the 
USA and Israel, found that approximately half of doctors used 
placebo medication in clinical practice.35–37 It should be noted 
that findings from such studies are based solely on question-
naires/interviews, where a reporting bias may contribute. The 
results cannot therefore be generalized to all doctors.
Benefiting from potential placebo effects is important 
in order to achieve an optimal result. Understanding the 
mechanisms behind placebo effects is therefore important for 
health care professionals. It is important to emphasize that 
exploiting the additional effects of a placebo mechanism is 
not the same as providing a full and pure placebo treatment. 
The placebo effect should not be a substitute for other more 
effective treatments.33,38
Biopsychosocial contextual factors (eg, factors related 
to the health care setting, to clinician-related factors, and 
to cultural factors) are important for treatment outcomes.10 
Placebo effects are one such contextual factor9 and cannot 
be separated from the whole context. Consequently, it is dif-
ficult to estimate the size or importance of placebo effects in 
a particular clinical setting. Put in different words, when a 
clinician activates placebo effects as additional effects, the 
clinician is making use of biopsychosocial contextual factors 
in such a way that this benefits the patient.
ways to elicit placebo effects
There are ways to induce the additional effects of the 
placebo mechanism (Table 1). Barrett et al39 suggest a 
list of eight specific and practical principles that doctors 
can use to elicit placebo effects. These include: speaking 
positively about treatments, providing encouragement, 
developing trust, providing reassurance, supporting rela-
tionships, respecting uniqueness, exploring values, and 
“creating ceremony”. The aim of using these principles is 
to create positive expectations, reduce anxiety/stress, and 
enhance the feeling of being cared for.39 These principles 
are fundamental and can be related to a biopsychosocial 
and patient-centered perspective.
It is important to communicate positive expectations 
regarding the outcome of the treatment and the patient’s abil-
ity to cope with the disease and its treatment.40 The doctor 
can do this, for instance, by providing information stating 
that a particular treatment is effective41–43 or by describing 
basic mechanisms behind the treatment.21,44,45 As an example, 
Benedetti and Amanzio46 recommend that negative sugges-
tions should be substituted with positive hints. For instance 
“here is your pain medicine” can be changed to “Here’s some 
medicine to help you get better”. Patients should have a clear 
understanding of the treatment and the desired outcome.44 
A central principle is thus to communicate realistic optimism 
and hope. Positive patient experiences with treatment may 
also lead to more long-lasting placebo effects due to a psy-
chological conditioning effect.41,47 
A trusting relationship between the doctor and the patient 
is central. Building confidence between patients and doctors 
is an important way of inducing placebo effects.40 Kaptchuk 
et al demonstrated this when they administered placebo 
without deception in patients with irritable bowel syndrome.48 
They obtained placebo effects based on the relationship 
between patients and health workers. Further, they found 
that switching from a technical style to a more emotionally 
warm/empathetic style increased the placebo effects from 
42% to 82%. Employing a patient-centered approach involv-
ing a cooperative and empathetic interactional style may 
help reduce patients’ anxiety and stress and thereby elicit 
additional positive placebo responses.28,29,40,46,49,50
ethical considerations
Clinicians need to consider some ethical issues relating to 
placebo effects. According to Pittrof and Rubenstein, the 
Table 1 Summary of central principles for using placebo as an 
additive effect in clinical practice
•  Describe basic mechanisms behind the treatment
•  Give information stating that the particular treatment is effective, 
provided that this information is realistic
•  Aim for an emotionally warm/empathetic style
•  Try to reduce the amount of stress for the patient





 ethical use of placebo effects should always benefit the patient 
and involve disclosure. Thus, clinicians should always give 
precise information about the treatment and possible side 
effects.33 Further, Pittrof and Rubenstein argue that it is 
unethical to ignore placebo effects because this phenomenon 
is so well documented.33 Placebo effects, when considered 
as supplements to pharmacologically active substances, 
should aim to increase patients’ well-being.38 It is unethi-
cal to deliberately misinform patients. Taking advantage of 
placebo effects as additive effects in clinical practice should 
not be confounded with deception. Deception is not ethical 
and can harm the relationship between clinicians and their 
patients. The ethical use of placebo effects in a clinical set-
ting should rely on realistic expectations and be based on 
best practice. The use of placebo in clinical settings might 
still be seen as controversial by some. However, provided that 
placebo effects are used as additional effects to best practice 
medicine, and provided there is no deception of the patient, 
we believe that placebo effects generally are unproblematic 
from an ethical perspective.
Summary
Placebo effects have been demonstrated in a number of 
experimental trials and clinical studies. These effects cause 
physiological responses, such as reduced activity in the 
pain-sensitive areas of the brain. It is possible to ethically 
apply the placebo effect as a supplement to active or verified 
treatments. Giving information stating that a particular treat-
ment is effective is ethical, provided that such information 
is realistic. The central principle is to build realistic hope 
and influence expectations. This may activate the effects of 
placebo and thereby improve the results of the treatment. 
This is a way to access the patient’s own healing potential 
as much as possible.
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